Skip to main content
. 2016 Mar 16;11(3):e0149685. doi: 10.1371/journal.pone.0149685

Fig 1. Flow chart of systematic review.

Fig 1

*One study could be included at 12 and 24 months. DMD: Disease Modifying Drug; FLDMD: First-line DMD; SLDMD: Second-line DMD; PCB: Placebo; BPF: Brain Parenchymal Fraction; SIENA: Structural Image Evaluation, using Normalisation, of Atrophy.